Folate‑polyethylene glycol conjugated carboxymethyl chitosan for tumor‑targeted delivery of 5‑fluorouracil

Li,Hai‑Lang; He,Ya‑Xing; Gao,Qian‑Hong; Wu,Guo‑Zhong

doi:10.3892/mmr.2014.1917

Folate‑polyethylene glycol conjugated carboxymethyl chitosan for tumor‑targeted delivery of 5‑fluorouracil

Authors:
- Hai‑Lang Li
- Ya‑Xing He
- Qian‑Hong Gao
- Guo‑Zhong Wu
View Affiliations

Affiliations: Department of Radiation Chemistry and Engineering, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, P.R. China
Published online on: January 23, 2014 https://doi.org/10.3892/mmr.2014.1917
Pages: 786-792

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Targeted drug delivery has been evolving at an increasing rate due to its potential to reduce the minimum effective dose of a drug and its accompanying side effects. It has shown improved therapeutic efficacy at equivalent plasma concentrations; however, the development of effective targeted delivery systems has remained a major task. In this study, a drug carrier was designed and synthesized by conjugation of folate acid (FA) to carboxymethyl chitosan (CMCS) through a polyethylene glycol (PEG) spacer. The resulting conjugates were confirmed by 1H nuclear magnetic resonance and infrared spectroscopy. The cytotoxicity of CMCS and CMCS‑5‑fluorouracil (5‑FU) was determined by a crystal violet stain assay. The potential of CMCS‑PEG‑FA for use in the targeted delivery of 5‑FU was investigated using 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide analysis in two cell lines, HeLa and A549, which contain different numbers of folate receptors on their surfaces. The MTT results revealed that in HeLa cells, the cytotoxicity of (CMCS‑5‑FU)‑PEG‑FU cells is greater compared with CMCS‑5‑FU, suggesting that folate receptor‑mediated endocytosis may affect the cellular uptake efficiency of 5‑FU‑loaded CMCS‑PEG‑FA. The CMCS‑PEG‑FA conjugates presented in this study show promise as carriers for chemotherapeutic agents due to their solubility at physiological pH, efficiency in carrying chemotherapeutic agents, low cytotoxicity and targeting ability.

View Figures

View References

1	Heidelberger C, Chaudhuri NK, Danneburg P, et al: Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature. 179:663–666. 1957. View Article : Google Scholar : PubMed/NCBI
2	Cai TB, Tang X, Nagorski J, Brauschweiger PG and Wang PG: Synthesis and cytotoxicity of 5-fluorouracil/diazeniumdiolate conjugates. Bioorg Med Chem. 11:4971–4975. 2003. View Article : Google Scholar : PubMed/NCBI
3	No authors listed. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 345:939–944. 1995. View Article : Google Scholar : PubMed/NCBI
4	Lin FH, Lee YH, Jian CH, Wong JM, Shieh MJ and Wang CY: A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials. 23:1981–1987. 2002. View Article : Google Scholar : PubMed/NCBI
5	Bleiberg H: Colorectal cancer - is there an alternative to 5-FU? Eur J Cancer. 33:536–541. 1997. View Article : Google Scholar : PubMed/NCBI
6	Riley SA and Turnberg LA: Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease. Q J Med. 75:551–562. 1990.PubMed/NCBI
7	Bartalsky A: Salicylazobenzoic acid in ulcerative colitis. Lancet. 319:9601982. View Article : Google Scholar
8	Ashford M, Fell J, Attwood D, Sharma H and Woodhead P: In vitro investigation into the suitability of pH dependent polymer for colonic targeting. Int J Pharm. 95:193–199. 1993. View Article : Google Scholar
9	Marvola M, Nykänen P, Rautio S, Isonen N and Autere AM: Enteric polymers as binders and coating materials in multiple-unit site-specific drug delivery systems. Eur J Pharm Sci. 7:259–267. 1999. View Article : Google Scholar : PubMed/NCBI
10	Gazzaniga A, Busetti C, Sangali ME and Giordana ME: Time-dependent oral delivery system for colonic targeting system for the colon targeting. STP Pharma Sci. 5:83–88. 1995.
11	Gazzaniga A, Iamartino P, Maffione G and Sangal ME: Oral delayed release system system for colonic specific delivery. Int J Pharm. 108:77–83. 1994. View Article : Google Scholar
12	Malet-Martino M and Martino R: Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. Oncologist. 7:288–323. 2002. View Article : Google Scholar : PubMed/NCBI
13	Malet-Martino M, Jolimaitre P and Martino R: The prodrugs of 5-fluorouracil. Curr Med Chem Anticancer Agents. 2:267–310. 2002. View Article : Google Scholar
14	Haller DG: An overview of adjuvant therapy for colorectal. Eur J Cancer. 31A:1255–1263. 1995. View Article : Google Scholar : PubMed/NCBI
15	Bajetta E, Di Bartolomeo M, Somma L, Del Vecchio M, Artale S, Zunino F, Bignami P, Magnani E and Buzzoni R: Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens. Eur J Cancer. 33:687–690. 1997. View Article : Google Scholar : PubMed/NCBI
16	Hovgaard L and Brondsted H: Dextran hydrogels for colon-specific drug delivery. J Control Release. 36:159–166. 1995. View Article : Google Scholar
17	Watts PJ and Lllum L: Colonic drug delivery. Drug Dev Ind Pharm. 23:893–913. 1997. View Article : Google Scholar
18	Saranya N, Moorthi A, Saravanan S, Devi MP and Selvamurugan N: Chitosan and its derivatives for gene delivery. Int J Biol Macromol. 48:234–238. 2011. View Article : Google Scholar : PubMed/NCBI
19	Lee KY, Kwon IC, Kim YH, Jo WH and Jeong SY: Preparation of chitosan self-aggregates as a gene delivery system. J Control Release. 51:213–220. 1998. View Article : Google Scholar : PubMed/NCBI
20	Hejazi R and Amiji M: Chitosan-based gastrointestinal delivery system. J Control Release. 89:151–165. 2003. View Article : Google Scholar : PubMed/NCBI
21	Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E and Fernandes JC: Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm. 57:1–8. 2004. View Article : Google Scholar : PubMed/NCBI
22	Dang JM and Leong KW: Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev. 58:487–499. 2006. View Article : Google Scholar : PubMed/NCBI
23	Chung YC, Kuo CL and Chen CC: Preparation and important functional properties of water-soluble chitosan produced through Maillard reaction. Bioresour Technol. 96:1473–1482. 2005. View Article : Google Scholar
24	Liu WG, Zhang X, Sun SJ, Sun GJ, Yao KD, Liang DC, Guo G and Zhang JY: N-alkylated chitosan as a potential nonviral vector for gene transfection. Bioconjug Chem. 14:782–789. 2003. View Article : Google Scholar : PubMed/NCBI
25	Mao S, Shuai X, Unger F, Wittmar M, Xie X and Kissel T: Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers. Biomaterials. 26:6343–6356. 2005. View Article : Google Scholar : PubMed/NCBI
26	Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al: ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 18:301–313. 2000.
27	Kircheis R, Schüller S, Brunner S, Ogris M, Heider KH, Zauner W, et al: Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med. 1:111–120. 1999. View Article : Google Scholar : PubMed/NCBI
28	Ogris M, Brunner S, Schuller S, Kircheis R and Wagner E: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:595–605. 1999. View Article : Google Scholar : PubMed/NCBI
29	Oupický D, Ogris M and Seymour LW: Development of long-circulating polyelectrolyte complexes for systemic delivery of genes. J Drug Target. 10:93–98. 2002.PubMed/NCBI
30	Nguyen HK, Lemieux P, Vinogradov SV, Gebhart CL, Guérin N, Paradis G, et al: Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7:126–138. 2000. View Article : Google Scholar : PubMed/NCBI
31	Choi YH, Liu F, Kim JS, Choi YK, Park JS and Kim SW: Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. J Control Release. 54:39–48. 1998. View Article : Google Scholar : PubMed/NCBI
32	Fernandez-Megia E, Novoa-Carballal R, Quiñoá E and Riguera R: Conjugation of bioactive ligands to PEG-grafted chitosan at the distal end of PEG. Biomacromolecules. 8:833–842. 2007. View Article : Google Scholar : PubMed/NCBI
33	Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M and Wagner E: Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release. 91:173–181. 2003. View Article : Google Scholar : PubMed/NCBI
34	Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, et al: Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 70:399–421. 2001. View Article : Google Scholar : PubMed/NCBI
35	Kim TH, Nah JW, Cho MH, Park TG and Cho CS: Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles. J Nanosci Nanotechnol. 6:2796–2803. 2006. View Article : Google Scholar : PubMed/NCBI
36	Hashimoto M, Morimoto M, Saimoto H, Shigemasa Y, Yanagie H, Eriguchi M and Sato T: Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages. Biotechnol Lett. 28:815–821. 2006. View Article : Google Scholar : PubMed/NCBI
37	Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F and Uekama K: Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates. J Control Release. 104:397–413. 2005. View Article : Google Scholar : PubMed/NCBI
38	Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, et al: Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials. 27:2060–2065. 2006. View Article : Google Scholar : PubMed/NCBI
39	Lee D, Lockey R and Mohapatra S: Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans. J Nanosci Nanotechnol. 6:2860–2866. 2006. View Article : Google Scholar : PubMed/NCBI
40	Murata J, Ohya Y and Ouchi T: Design of quaternary chitosan conjugate having antennary galactose residues as a gene delivery tool. Carbohydr Polym. 32:105–119. 1997. View Article : Google Scholar
41	Gao S, Chen J, Xu X, Ding Z, Yang YH, Hua Z and Zhang J: Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm. 255:57–68. 2003. View Article : Google Scholar : PubMed/NCBI
42	Kim TH, Park IK, Nah JW, Choi YJ and Cho CS: Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials. 25:3783–3792. 2004. View Article : Google Scholar : PubMed/NCBI
43	Hashimoto M, Morimoto M, Saimoto H, Shigemasa Y and Sato T: Lactosylated chitosan for DNA delivery into hepatocytes: the effect of lactosylation on the physicochemical properties and intracellular trafficking of pDNA/chitosan complexes. Bioconjug Chem. 17:309–316. 2006. View Article : Google Scholar : PubMed/NCBI
44	Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR Jr and Kamen BA: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:3396–3401. 1992.PubMed/NCBI
45	Antony AC: Folate receptors. Annu Rev Nutr. 16:501–521. 1996. View Article : Google Scholar
46	Lee RJ and Low PS: Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem. 269:3198–3204. 1994.PubMed/NCBI
47	Lee RJ and Low PS: Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochem Biophys Acta. 1233:134–144. 1995. View Article : Google Scholar : PubMed/NCBI
48	Ross JF, Chaudhuri PK and Ratnam M: Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer. 73:2432–2443. 1994. View Article : Google Scholar : PubMed/NCBI
49	Kamaly N, Kalber T, Thanou M, Bell JD and Miller AD: Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjug Chem. 20:648–655. 2009. View Article : Google Scholar : PubMed/NCBI
50	Zheng Y, Cai Z, Song X, Chen Q, Bi Y, Li Y and Hou S: Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies. J Drug Target. 17:294–303. 2009. View Article : Google Scholar
51	Hwa Kim S, Hoon Jeong J, Chul Cho K, Wan Kim S and Gwan Park T: Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J Control Release. 104:223–232. 2005.PubMed/NCBI
52	Hwa Kim S, Hoon Jeong J, Co Joe and Gwan Park T: Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate. J Control Release. 103:625–634. 2005.PubMed/NCBI
53	Liang B, He ML, Xiao ZP, et al: Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery. Biochem Biophys Res Commun. 367:874–880. 2008. View Article : Google Scholar : PubMed/NCBI
54	Benns JM, Mahato RI and Kim SW: Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J Control Release. 79:255–269. 2002. View Article : Google Scholar : PubMed/NCBI
55	Benns JM, Maheshwari A, Furgeson DY, Mahato RI and Kim SW: Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target. 9:123–139. 2001. View Article : Google Scholar : PubMed/NCBI
56	Cheng H, Zhu JL, Zeng X, Jing Y, Zhang XZ and Zhuo RX: Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity. Bioconjug Chem. 20:481–487. 2009. View Article : Google Scholar : PubMed/NCBI
57	Kim SH, Mok H, Jeong JH, Kim SW and Park TG: Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug Chem. 17:241–244. 2006. View Article : Google Scholar : PubMed/NCBI
58	Corsi K, Chellat F, Yahia L and Fernandes JC: Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials. 24:1255–1264. 2003. View Article : Google Scholar : PubMed/NCBI